New wound dressing aims to speed healing in chronic wounds

NCT ID NCT07576322

Not yet recruiting Disease control Sponsor: Sebastian Probst Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares a new dressing called POLTX_Fiber to a standard one for chronic wounds like leg ulcers and pressure sores. Sixty adults with moderate-to-heavy wound drainage will be followed for 30 days. Researchers will track healing, infection, pain, and patient satisfaction to see if the new dressing performs better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: POLTX_Fiber dressing
What this could lead to: If successful, this could show that POLTX_Fiber is a safe and effective option for managing chronic wounds, potentially improving healing and reducing infection risk.
What could go wrong: This is a small, early-stage study with only 60 participants, so results may not apply to everyone. The dressing is already approved, so major breakthroughs are unlikely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC WOUND are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic ulcer of skin infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC WOUND CARE LOCAL INFECTION SAFETY

Contacts and locations

Locations

Geneva University Hospitals

Geneva, Canton of Geneva, 1205, Switzerland
Instituions Hospital Du Nord Vaudois

Yverdon-les-Bains, Canton of Vaud, 1400, Switzerland
Lausanne University Hospital

Lausanne, Canton of Vaud, 1002, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.